Friday, July 08, 2022 10:28:06 AM
Multiple Sclerosis Trials
Government Grants for validation of NPHC Nerve Agent Countermeasure
Adding to NPHC's 21 Patents
Additional Social Media Endorsements
New Products from NPHC
Here is what Deitsch the CEO has done for NPHC in 19 years:
Pink Current Status
Added Many patents and trademarks to Nutra's portfolio
Clinical Trials in Multiple Phases
1. Multiple Sclerosis Trials
2. Herpes Simplex Infections 1 & 2 Trials
3. Adrenomyeloneuropathy Trials
4. HIV Trials
5. Amyotrophic Lateral Sclerosis Trials
6. Rheumatoid Arthritis Trials
7. Pain Trials
Products launched and brought to Market
1. Cobroxin
2. Nyloxin
3. Pet Pain Away
4. Equine pain Away
5. Luxury Feet
Published Research
http://receptopharm.com/drug_development/published_research.php
https://www.nutrapharma.com/research
Increased Sales on Amazon and Walmart
RPI-78M has received Orphan Drug Designation from the FDA for the treatment of Pediatric Multiple Sclerosis
Huge personal loans from Deitsch to NPHC tells me the CEO knows and believes in NPHC
Nyloxin, I put that Sh*t on everything!!!
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM